328 related articles for article (PubMed ID: 8379943)
1. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
Ul-Haq R; Chitambar CR
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
[TBL] [Abstract][Full Text] [Related]
2. Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells.
Chitambar CR; Wereley JP
Blood; 1998 Jun; 91(12):4686-93. PubMed ID: 9616166
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea.
Chitambar CR; Matthaeus WG; Antholine WE; Graff K; O'Brien WJ
Blood; 1988 Dec; 72(6):1930-6. PubMed ID: 3058232
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.
Chitambar CR; Sax D
Blood; 1992 Jul; 80(2):505-11. PubMed ID: 1627803
[TBL] [Abstract][Full Text] [Related]
5. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
Ishiguro K; Ho PT; Sartorelli AC
Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
[TBL] [Abstract][Full Text] [Related]
7. Modulation of lymphocyte proliferation and immunoglobulin production by transferrin-gallium.
Chitambar CR; Seigneuret MC; Matthaeus WG; Lum LG
Cancer Res; 1989 Mar; 49(5):1125-9. PubMed ID: 2537143
[TBL] [Abstract][Full Text] [Related]
8. Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron.
Alcantara O; Javors M; Boldt DH
Blood; 1991 Mar; 77(6):1290-7. PubMed ID: 2001452
[TBL] [Abstract][Full Text] [Related]
9. Regulation of transferrin receptor expression in myeloid leukemia cells.
Taetle R; Ralph S; Smedsrud S; Trowbridge I
Blood; 1987 Sep; 70(3):852-9. PubMed ID: 3476165
[TBL] [Abstract][Full Text] [Related]
10. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
Chitambar CR; Wereley JP
Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
[TBL] [Abstract][Full Text] [Related]
11. Transferrin receptor-mediated suppression of in vitro hematopoiesis by transferrin-gallium.
Chitambar CR; Craig A; Ash RC
Exp Hematol; 1989 Jun; 17(5):418-22. PubMed ID: 2714421
[TBL] [Abstract][Full Text] [Related]
12. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
[TBL] [Abstract][Full Text] [Related]
13. Iron-transferrin-induced increase in protein kinase C activity in CCRF-CEM cells.
Phillips JL; Boldt DH; Harper J
J Cell Physiol; 1987 Aug; 132(2):349-53. PubMed ID: 3497931
[TBL] [Abstract][Full Text] [Related]
14. Expression of the hemochromatosis (HFE) gene modulates the cellular uptake of 67Ga.
Chitambar CR; Wereley JP
J Nucl Med; 2003 Jun; 44(6):943-6. PubMed ID: 12791823
[TBL] [Abstract][Full Text] [Related]
15. Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition.
Chitambar CR; Wereley JP; Matsuyama S
Mol Cancer Ther; 2006 Nov; 5(11):2834-43. PubMed ID: 17121930
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of transferrin receptor expression by cultured lymphoblastoid T cells treated with phorbol diesters.
Alcantara O; Denham CA; Phillips JL; Boldt DH
J Immunol; 1989 Mar; 142(5):1719-26. PubMed ID: 2783948
[TBL] [Abstract][Full Text] [Related]
17. Combination iron depletion therapy.
Taetle R; Honeysett JM; Bergeron R
J Natl Cancer Inst; 1989 Aug; 81(16):1229-35. PubMed ID: 2666676
[TBL] [Abstract][Full Text] [Related]
18. Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium.
Chitambar CR; Narasimhan J
Pathobiology; 1991; 59(1):3-10. PubMed ID: 1645976
[TBL] [Abstract][Full Text] [Related]
19. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
Hedley D; Rugg C; Musgrove E; Taylor I
J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
[TBL] [Abstract][Full Text] [Related]
20. Effect of transcription inhibitors on the iron-dependent degradation of transferrin receptor mRNA.
Seiser C; Posch M; Thompson N; Kühn LC
J Biol Chem; 1995 Dec; 270(49):29400-6. PubMed ID: 7493976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
